PET/CT mediastinal and liver FDG uptake: Effects of biological and procedural factors

Journal of Medical Imaging and Radiation Oncology

Volumn 57, Issue 2, 2013, Pages 169-175

  Malladi, Ashish ^a,b   Viner, Maya ^a,b   Jackson, Tatianie ^a,b   Mercier, Gustavo ^a,b   Subramaniam, Rathan M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

body mass index; FDG; incubation; intravenous contrast; quantitation; standardised uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOVERSOL;

ADOLESCENT; ADULT; AGED; BODY MASS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCUBATION TIME; LEAN BODY WEIGHT; LINEAR REGRESSION ANALYSIS; LIVER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; UNIVARIATE ANALYSIS;

AGE DISTRIBUTION; AGING; BODY MASS INDEX; BOSTON; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; METABOLIC CLEARANCE RATE; MIDDLE AGED; MULTIMODAL IMAGING; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; TISSUE DISTRIBUTION;

EID: 84875857186     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12015     Document Type: Review

References (27)

1. Wahl RL, Jacene H, Kasamon Y, Lodge MA,. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50 (Suppl 1): 22S-50S.
2. Hillner BE, Siegel BA, Liu D, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol 2008; 26: 2155-2161.
3. Weber WA, Czernin J, Phelps ME,. Prognostic significance of fluorodeoxyglucose uptake in non-small cell lung cancer. A blurry picture? Clin Cancer Res 2007; 13: 3105-3106.
4. Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G,. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol 2010; 31: 598-604.
5. Davison JM, Ozonoff A, Imsande HM, Grillone GA, Subramaniam RM,. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. Radiology 2010; 255: 578-585.
6. Imsande HM, Davison JM, Truong MT, et al. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma. AJR Am J Roentgenol 2011; 197: 976-980.
7. Karantanis D, Subramaniam RM, Peller PJ, et al. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma 2008; 8: 94-99.
8. Karantanis D, O'Eill BP, Subramaniam RM, et al. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun 2007; 28: 834-841.
9. Hadiprodjo D, Ryan T, Truong MT, Mercier G, Subramaniam RM,. Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters. AJR Am J Roentgenol 2012; 198: W185-190
10. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA,. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004; 45: 1519-1527.
11. Boellaard R,. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009; 50: 11S-20.
12. Perri M, Erba P, Volterrani D, et al. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis. AJR Am J Roentgenol 2011; 197: 209-216.
13. Ozcan Kara P, Kara T, Kara Gedik G, et al. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions. Nucl Med Commun 2011; 32: 106-112.
14. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-578.
15. Shiono S, Abiko M, Okazaki T, Chiba M, Yabuki H, Sato T,. Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value. Eur J Cardiothorac Surg 2011; 40: 1165-1169.
16. Lin CY, Ding HJ, Lin CC, Chen CC, Sun SS, Kao CH,. Impact of age on FDG uptake in the liver on PET scan. Clin Imaging 2011; 34: 348-350.
17. Kubota K, Watanabe H, Murata Y, et al. Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study. Nucl Med Biol 2011; 38: 347-351.
18. Kamimura K, Nagamachi S, Wakamatsu H, et al. Associations between liver (18)F fluoro-2-deoxy-D-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome. Ann Nucl Med 2010; 24: 157-161.
19. Basu S, Kung J, Houseni M, Zhuang H, Tidmarsh GF, Alavi A,. Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions. Q J Nucl Med Mol Imaging 2009; 53: 9-19.
20. Abikhzer G, Alabed YZ, Azoulay L, Assayag J, Rush C,. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT. AJR Am J Roentgenol 2011; 196: 176-180.
21. Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL,. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 1999; 213: 521-525.
22. Zasadny KR, Wahl RL,. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189: 847-850.
23. Abele JT, Fung CI,. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Radiology 2010; 254: 917-924.
24. Choi Y, Hawkins RA, Huang SC, et al. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. J Nucl Med 1994; 35: 818-823.
25. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN,. FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 1998; 39: 1030-1033.
26. Adams MC, Turkington TG, Wilson JM, Wong TZ,. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 2010; 195: 310-320.
27. Bunyaviroch T, Turkington TG, Wong TZ, Wilson JW, Colsher JG, Coleman RE,. Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements. Mol Imaging Biol 2008; 10: 107-113.